Kilinc, S. And SEVGİLİ, A. M. 2022. Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug. GAZI MEDICAL JOURNAL , vol.33, no.1 , 108-113.

Kilinc, S., & SEVGİLİ, A. M., (2022). Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug. GAZI MEDICAL JOURNAL , vol.33, no.1, 108-113.

Kilinc, Sevtap, And AYŞE MELTEM SEVGİLİ. "Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug," GAZI MEDICAL JOURNAL , vol.33, no.1, 108-113, 2022

Kilinc, Sevtap And SEVGİLİ, AYŞE M. . "Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug." GAZI MEDICAL JOURNAL , vol.33, no.1, pp.108-113, 2022

Kilinc, S. And SEVGİLİ, A. M. (2022) . "Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug." GAZI MEDICAL JOURNAL , vol.33, no.1, pp.108-113.

@article{article, author={Sevtap Kilinc And author={AYŞE MELTEM SEVGİLİ}, title={Nonalcoholic Fatty Liver Disease and Topiramate as an Antiobesity Drug}, journal={GAZI MEDICAL JOURNAL}, year=2022, pages={108-113} }